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Abstract
Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system 
characterized by the destruction of myelin sheaths and axonal loss. Presenting symptoms of multiple sclerosis may 
vary and if not promptly identified may lead to a delayed diagnosis of Multiple sclerosis. 
In this paper, we present a rare case of a patient with ageusia as presenting symptom of Multiple sclerosis; the symptom 
spontaneously resolved after two weeks and was followed by hyposmia, dizziness, tinnitus and facial paraesthesia that 
eventually led to a clinical diagnosis of Multiple sclerosis.
The presence of gustatory, olfactory and audio-vestibular symptoms has been associated with disease activity and 
progression of several inflammatory and neurodegenerative diseases of the central nervous system including Multiple 
sclerosis. Gustatory alterations may be due to the presence of demyelinating lesion in the brain area of taste; the 
progression of the disease may explain the additional olfactory and audio-vestibular symptoms described in this patient.
Even if taste alteration is an extremely rare presenting symptom of Multiple sclerosis, its presence in young women 
should always be carefully investigated as it could be an early sign of Multiple sclerosis.
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INTRODUCTION
Multiple Sclerosis (MS) is a chronic inflammatory and 
neurodegenerative disease of the Central Nervous System 
(CNS) characterized by the progressive destruction of 
myelin sheaths and axonal loss, typically presenting in 
the third and fourth decade of life1. The demyelination 
may affect different areas of brain and medulla and 
be responsible of different otolaryngologic symptoms 
including gustatory, olfactory, and audio-vestibular 
alterations1.
MS may alter the olfactory and gustatory functions at 
both the functional and structural levels2; the neurological 
symptoms may vary depending on the brain region 
affected by demyelination. The olfactory function is altered 
in 15% to 45% of patients that suffer from MS3,4, while taste 
is altered in only 4% of cases. The combination between 
olfactory and taste alterations is reported in nearly 19% 
of MS patient5. Based on self-report or cursory sensory 
testing, MS-related taste disorders have been assumed 
to be rare6; furthermore, patients reporting taste deficits 
typically have associated olfactory dysfunction, and may 
be inaccurate in recognizing true taste dysfunction when 
present. The smell dysfunction that could increase the 
taste alteration is progressive and slowly deteriorates 
over time4,7,8 the increasing of smell dysfunction impacts 
taste also by increasing the symptom4,5,9,10. 
Audio-vestibular symptoms, such as sudden, transient 
or progressive sensorineural hearing loss, tinnitus and 
dizziness are common in patients with MS, and have a 
significant impact on quality of life of affected subjects11. 
Audio-vestibular symptoms may arise from central 
alterations, such as demyelination in the auditory or 
vestibular pathways, or more rarely can be peripheral, 
following the involvement of the peripheral audio-
vestibular system12-14. 
Olfactory, gustatory and audio-vestibular symptoms 
are often of temporary nature, probably because of the 
relapsing/remitting events that occur during the course 
of MS or following the use of corticosteroids that contrast 
the systemic inflammation generated by MS15.
In this article, we report the case of a young woman 
presenting with a complete loss of taste that spontaneously 
resolved after two weeks, gradually followed by olfactory, 
audio-vestibular and neurological symptoms that led to a 
clinical diagnosis of MS.
CASE REPORT 
A 32 years old woman was admitted to the Neurology 
Department of the Policlinico Umberto I, Sapienza 
University of Rome, referring the occurrence of a 
complete loss of taste (ageusia) nearly 3 months before 
admission with spontaneous resolution two weeks later. 
Ageusia was followed, about one week after its resolution, 
by hyposmia, dizziness and tinnitus in the absence of 
subjective hearing loss, and present at admission. One 
week before admission, the patient also experienced 
the loss of strength in the left side of the body and facial 
paraesthesia that led the patient to seek for medical help. 
In her medical history, she denied previous neurological 
disease and referred insulin resistance in treatment with 
metformin and hypothyroidism. After admission, the 
patient underwent a comprehensive neurological and 
otolaryngologic examination.
Neurological examination revealed a slight gait abnormality 
and little movements towards the left side when eyes were 
closed. Tactile sensitivity showed no disturbances at time 
of the evaluation. Brainstem Auditory Evoked Responses 
(BAER) Table 1, Motor Evoked Potentials (MEPs) Table 2, 
Visual Evoked Potentials (VEP) Table 3 was normal.
Otolaryngology examination including nasal endoscopy 
did not yield to any significant abnormalities. Tonal 
audiometry demonstrated bilateral normal hearing 
defined as an individual hearing threshold <25 dB HL 
at frequencies from 250 to 4,000 Hz at the octave scale 
in both ears according to the American Academy of 
Otolaryngology and American Council of Otolaryngology 
Figure 1. The measurement of the characteristics of 
tinnitus indicated a bilateral continuous non-pulsatile 
tinnitus with a frequency near 3000 Hz and an intensity 
of 20 dB. The Italian versions of the Tinnitus Handicap 
Inventory (THI)16 and Hearing Handicap Inventory (HHI)17 
questionnaires were administered to the patients. THI 




I (ms) III (ms) V (ms) III-V (ms)
S-BAER
Ipsilateral 75 nHL 1.74 3.92 5.7 1.78
Contralateral 3.8 5.9 2.1
D-BAER
Ipsilateral 75 nHL 1.88 3.96 5.94 1.98
Contralateral   3.98 5.98 2
Table 1: Brainstem auditory evoked responses [Brainstem Auditory 










S-ULNAR ADM S-TIBIAL MALLEOLUS
Cortical 20.15 10.15 Cortical 26.95 19.75
Radicolar 10 Radicolar 7.2
D-ULNAR ADM D-TIBIAL MALLEOLUS
Cortical 19.1 9.05 Cortical 27.65 20.05
Radicolar 10.1  Radicolar 7.6  
Table 2: Motor Evoked Responses [Motor Evoked Response recording 
in the present case. Values were within normal range].
Stimulus (B/N) Right eye Left eye
 
Latency (ms) Latency (ms)
109 110
Amplitude (mV) Amplitude (mV)
7.6 6.05
Table 3: Visual Evoked Responses [Visual Evoked Response 
recording in the present case. Values were within normal range].
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similar alterations were observed in the left medium and 
lower cerebellar peduncles. 
Due to clinical and radiologic features suggesting a 
demyelinating disease, the patients underwent a lumbar 
puncture. Cerebrospinal Fluid (CSF) analysis showed the 
presence of oligoclonal bands suggestive of MS.
Further autoimmunity evaluation was performed including 
testing for antinuclear antibody, double-strand DNA 
antibody, phospholipid antibody, cardiolipin antibody, 
antineutrophil cytoplasmic antibody and perinuclear 
antineutrophil cytoplasmic antibody. All tests were 
negative.
A diagnosis of relapsing-remitting MS was made, and the 
patient started an immunomodulatory treatment with solu-
medrol. Associated symptoms promptly disappeared 
after the initiation of the treatment. No further relapses 
were observed for the subsequent 6 months.
DISCUSSION 
Taste, olfactory and audio-vestibular alterations have 
been recognized as important presenting symptoms in 
various neurodegenerative and neuroinflammatory CNS 
conditions23 and have been reported in patients with MS.
Taste disorders in MS
The presence of gustatory alterations, as observed in our 
patient, represents an often underestimated condition in 
MS patients because of their rarity as presenting symptoms 
and because they are often associated to additional smell 
alterations that may confuse the identification of real true 
taste dysfunctions by the patients when present24.
The impairment of taste perception had been reported 
in approximately 20% of MS patients25 with elevated 
electrogustometric thresholds. Patients suffering from MS 
showed difficulties to identify tastants for all four classic 
taste qualities on both anterior (VII) and posterior regions 
of the tongue (IX); this loss of sensibility may be due to 
the involvement of superior taste pathways that influence 
taste quality more than perceived strength25 Figure 3.
Combarros et al. described the case of a patient 
lamenting transitory gustatory dysfunction that presented 
hyperintense, enhanced small lesion in the lateral part 
of the left midpontine tegmentum at MRI; this finding 
supports the hypothesis that unilateral pontine lesions 
may result in ipsilateral gustatory deficits and suggests 
that gustatory fibers ascend from the solitary nucleus in 
the medulla up to the homolateral pontine tegmentum 
without decussating26. In a different case, bilateral 
gustatory alteration has been reported in a patient with 
a unilateral small lesion, suggesting that the ascending 
gustatory fibers branch at the level of the lesion in the 
lower midbrain or in the more caudal part9.
In our case, the patient presented a complete loss of 
taste lasting for two weeks with a spontaneous recovery. 
performed to evaluate the presence somatic tinnitus18-22; 
all maneuvers on the temporomandibular joint and head 
and neck did not induce a modulation of tinnitus pitch 
or loudness, thus excluding a somatosensory origin of 
tinnitus.
Distortion-product Otoacoustic Emissions (DPOAEs) 
were recorded and were consistent with audiometric 
findings Figure 2 although a bilateral decrease of DP 
intensity was recorded for frequencies between 4,358 
and 5,188 Hz.
Vestibular evaluation revealed a spontaneous brief 
right-beating horizontal nystagmus, although Fitzgerald-
Hallpike caloric testing was normal.
In the suspicion of a CNS disease, an MRI of the brain 
was performed, reveling the presence small areas of 
hyperintensity in FLAIR sequences in the periventricular 
space, in the semioval center and at the level of the corona 
radiata, compatible with multifocal leukoencephalopathy; 
Figure 1: Pure Tone Audiometry showing a bilateral normal hearing.
Figure 2: Distortion Product Otoacoustic Emissions were within 
normal range.
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Ageusia was the only presenting symptom and was 
not associated with other symptoms, that instead 
appeared only several weeks later and led the patient 
to seek for neurological evaluation. In her MRI, areas 
of demyelination were identified in the semioval center 
and at the level of the corona radiata that may explain 
the alteration of taste; in fact, corona radiata in particular 
has been identified as responsible for taste alteration. The 
explanation of this phenomenon is linked to the pathways 
of the gustatory fibers that ascend contralaterally in the 
cerebral hemisphere and that then ascend from the 
thalamus to the cerebral cortex via the posterior part of 
corona radiata.
Smell alterations in MS
MS patients may present olfactory alterations that lead 
to odors misidentification and that are mainly present 
during the active phases of the disease. The MS olfactory 
dysfunctions are often associated to demyelination in 
the frontal and temporal lobes7. These findings suggest 
that smell impairment might be an effective indicator of 
disease progression due to the increasing in number of 
brain lesions, even in the presence of VEP within normal 
range23.
The incidence of smell disorders in patients with MS is 
still controversial; percentages range from 15% to 45% 
in case control studies27-31. A worse olfactory threshold 
was observed in the early inflammatory phases while an 
identification score was more impaired in the widespread 
chronic disease. The presence of demyelinating plaques 
observed by MRI in the inferior frontal- and temporal-
lobe regions of patients affected from MS is correlated 
with altered smell abilities and olfactory dysfunctions. As 
in case of gustatory alterations, the olfactory dysfunction 
may be an indicator of disease progression due to the 
increasing of number of lesion or to the extension of 
demyelinating areas32,33.
The mechanisms that link CNS inflammation and olfactory 
dysfunction are still poorly understood. The smell 
threshold alteration is considered as associated with 
the peripheral parts of the olfactory system, while odor 
discrimination is related to a central process by engaging 
several brain regions23,24. Therefore, in advanced stages 
of MS, the odor identification may be gradually impaired 
as the disease progresses in the CNS and may impair 
the neuronal network required for the processing of odor 
information7. Furthermore, the inflammation in the brain 
may also affect the peripheral portion of the olfactory 
system via humoral mechanisms such as cytokine 
release or antibody-mediated inflammation7. In our case, 
hyposmia was not a presenting symptom and was not 
associated to ageusia; in fact, its onset followed the 
spontaneous remission of taste alteration.
Audio-vestibular alterations in MS
Audio-vestibular symptoms such as hearing loss, tinnitus 
and vertigo have been often reported in patients with MS. 
Audio-vestibular alterations, especially in young subjects, 
could represent an early sign of MS even when no 
demyelinated plaques are visible in the central nervous 
system13.
Tinnitus in MS patients is most probably a consequence 
of hearing impairment that affects between 1% and 17% 
of MS patients and is commonly attributed to central 
nervous system demyelination34. Hearing loss and 
tinnitus may be the only presenting symptom of MS and 
may appear early in the course of the disease with good 
prognosis and little or no residual hearing deficit13,15.
In the present case, tinnitus was not associated to 
clinically evident hearing loss; it has been previously 
reported that lesions affecting the auditory pathways may 
not determine an evident hearing loss in some cases15. 
Moreover, tinnitus and difficulties in speech perception, 
especially in noise, are often reported even in the absence 
of a clinically evident hearing loss35,36. Traditional theories 
assume that tinnitus is triggered by cochlear damage, 
mainly at the outer hair cell level; however, this would 
not apply to tinnitus patients presenting with a normal 
audiogram36,37. Recent findings have shown that normal 
hearing thresholds may also be found in patients with 
cochlear damage that predominantly affects specific 
structures, such as the inner hair cells, the auditory nerve 
fibers and the synapses between them38,39. An alteration 
of these cell populations, especially in the high-frequency 
region of the cochlea, may configure the presence of 
hidden hearing loss that cannot be recorded using the 
clinical audiometry38-41.
Figure 3: Graphic showing the taste pathways from tongue to the 
central brain areas.
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Vertigo affects 7% to 30% of patients with MS and is 
mainly attributed to demyelination of the vestibular nuclei, 
musculoskeletal weakness, and ocular diseases11. The 
most typical vestibular sign in MS patients is multidirectional 
nystagmus without latency42; dizziness and disequilibrium 
may be also present, while acute vertigo episodes are rarer. In 
these cases, differential diagnosis with peripheral vestibular 
disorders is of paramount importance; clinical signs such as 
adaptation and fatigue of nystagmus, and instrumental tests 
such as vestibular evoked myogenic potentials may play a 
role for the differential diagnosis42.
Recent evidences of the presence of macrophages in 
human temporal bones of patients with autoimmune 
disease supports the hypothesis that inflammation 
mechanisms in MS may also affect the inner ear leading to 
growing pathophysiological evidence of the involvement 
of the inner ear and vestibulocochlear nerve in hearing 
loss and vertigo in MS patients that may manifest with 
sudden sensorineural hearing loss and acute vertigo43.
Audio-vestibular symptoms in young, neurologically 
normal subjects, especially when spontaneous recovery 
occurs, may represent an early sign of MS; it is therefore 
recommended to evaluate these subjects with clinical, 
radiological and electrophysiological test to exclude 
peripheral incipient MS13,44.
CONCLUSION
In the present case, the presenting symptom of MS was 
a two-week long ageusia that spontaneously resolved 
without medical intervention. After its remission, ageusia 
was followed by other otolaryngologic symptoms such as 
olfactory and audio-vestibular alterations. These symptoms 
have been rarely reported, especially when simultaneous, 
in the early phase of MS and in young patients. A careful 
prompt investigation with clinical, radiological, and 
electrophysiological tests are recommended in patients 
with similar symptoms, especially in case of spontaneous 
recovery, as they may be presenting symptoms of a CNS 
disease such as an incipient MS.
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